Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price shot up 1.8% on Tuesday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The company has a fifty day moving average of C$0.58 and a two-hundred day moving average of C$0.58. The company has a market cap of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Read More
- Five stocks we like better than Acasti Pharma
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
